• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAmgen

Amgen

0
HealthThese 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By Sy MukherjeeJanuary 7, 2017
The Davos World Economic Forum 2015
HealthNovartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By Sy MukherjeeAugust 31, 2016
The Davos World Economic Forum 2015
HealthAmgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis
By Sy MukherjeeJuly 19, 2016
Close up of surgical tools and money
HealthTwo of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
By Sy MukherjeeJuly 15, 2016
483106863
HealthDrug Companies Really Don’t Care About the Price Hike Backlash
By Sy MukherjeeJuly 14, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck to Axe Jobs As Part of New Research Focus
By Sy MukherjeeJuly 13, 2016
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
HealthThis Is the Most Important Business Trend in Pharma
By Sy MukherjeeJune 21, 2016
FRANCE-ECONOMY-PHARMACEUTICALS-SANOFI
HealthSanofi Is Shuffling Its Exec Roster Amid Continued Struggles
By Sy MukherjeeMay 23, 2016
155292424
HealthAnother Major Insurer Is Tying Drug Prices to Health Outcomes
By Sy MukherjeeMay 11, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
FinanceBiotech Stocks Are Down 25% So Far This Year
By Sy MukherjeeMay 6, 2016
An Amgen sign is seen at the company's office in South San Francisco
HealthAmgen Just Won a Major Drug Patent Case Against Its Rivals
By Sy MukherjeeMarch 16, 2016
FinanceDaniel Loeb urges Amgen to split into two companies
By ReutersOctober 21, 2014
0
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.